Costa Rica approves dengue vaccine, Dengvaxia: 5th country to approve
by Press Release from Outbreak News Today on (#1J5AD)
On Wednesday, Sanofi Pasteur, Sanofi's vaccine division, announced that the National Ministry of Health of Costa Rica has approved Sanofi Pasteur's tetravalent dengue vaccine, Dengvaxia(R), to protect individuals 9 to 45 years of age living in endemic areas against all four serotypes of dengue. This approval in Costa Rica is the fourth registration of the ["]
